References
- Gorlin RJ, Cervenka J, Pruzansky S. Facial clefting and its syndromes. Birth Defects Orig Artic Ser. 1971; 7:3-49.4950925
- Mai CT, Cassell CH, Meyer RE, Isenburg J, Canfield MA, National Birth Defects Prevention Network. Birth defects data from population-based birth defects surveillance programs in the United States, 2007 to 2011: highlighting orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014; 100:895-904.
- Young DL, Schneider RA, Hu D, Helms JA. Genetic and teratogenic approaches to craniofacial development. Crit Rev Oral Biol Med. 2000; 11:304-17.1102163210.1177/10454411000110030201
- Lu XC, Yu W, Tao Y, Zhao PL, Li K, Tang LJ, et al. Contribution of transforming growth factors polymorphisms to nonsyndromic orofacial clefts: a HuGE review and meta-analysis. Am J Epidemiol. 2014; 179:267-81.10.1093/aje/kwt26224243742
- Blanton SH, Cortez A, Stal S, Mulliken JB, Finnell RH, Hecht JT. Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A. 2005; 137A:259-62.1609699510.1002/ajmg.a.30887
- Hunt S, Russell A, Smithson WH, Parsons L, et al.; UK Epilepsy and Pregnancy Register. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology. 2008; 71:272-6.10.1212/01.wnl.0000318293.28278.3318645165
- Jackson A, Bromley R, Morrow J, Irwin B, Clayton-Smith J. In utero exposure to valproate increases the risk of isolated cleft palate. Arch Dis Child Fetal Neonatal Ed. 2016; 101:F207-11.10.1136/archdischild-2015-30827826408639
- Pasternak B, Svanström H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013; 368:814-23.10.1056/NEJMoa121103523445092
- Shaw GM, Wasserman CR, Lammer EJ, O’Malley CD, Murray JC, Basart AM, et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet. 1996; 58:551-61.8644715
- Shaw GM, Lammer EJ. Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Pediatr. 1999; 134:298-303.10.1016/S0022-3476(99)70453-110064665
- Johnson C Y, Little J. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol. 2008; 37:1041-58.1858339310.1093/ije/dyn098
- Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2004; 70:846-52.1552366410.1002/bdra.20081
- Hernández-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000; 343: 1608-14.1109616810.1056/NEJM200011303432204
- Ittiwut R, Siriwan P, Suphapeetiporn K, Shotelersuk V. Epidemiology of cleft lip with or without cleft palate in Thais. Asian Biomed. 2016; 10:335-8.
- Maarse W, Bergé SJ, Pistorius L, van Barneveld T, Kon M, Breugem C, et al. Diagnostic accuracy of transabdominal ultrasound in detecting prenatal cleft lip and palate: a systematic review. Ultrasound Obstet Gynecol. 2010; 35:495-502.10.1002/uog.747220235140
- Cockell A, Lees M. Prenatal diagnosis and management of orofacial clefts. Prenat Diagn. 2000; 20:149-51.10.1002/(SICI)1097-0223(200002)20:2<149::AID-PD764>3.0.CO;2-U